blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2970116

EP2970116 - ARYL SULFAMIDE AND SULFAMATE DERIVATIVES AS RORc MODULATORS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  12.10.2018
Database last updated on 17.07.2024
FormerExamination is in progress
Status updated on  02.02.2018
Most recent event   Tooltip12.10.2018Application deemed to be withdrawnpublished on 14.11.2018  [2018/46]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[N/P]
Former [2016/03]For all designated states
F.Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
Inventor(s)01 / BODIL VAN NIEL, Monique
8/9 Spire Green Centre
Flex Meadow
Harlow Essex CM19 5TR / GB
02 / FAUBER, Benjamin
1 DNA Way
South San Francisco, California 94080 / US
03 / RENE, Olivier
1 DNA Way
South San Francisco, California 94080 / US
04 / WARD, Stuart
8/9 Spire Green Centre
Flex Meadow
Harlow Essex CM19 5TR / GB
 [2016/03]
Representative(s)Bernard, Guillaume
F. Hoffmann-La Roche AG
Patent Department
Grenzacherstrasse 124
4070 Basel / CH
[2016/03]
Application number, filing date14709306.612.03.2014
[2016/03]
WO2014EP54764
Priority number, dateUS201361790271P15.03.2013         Original published format: US 201361790271 P
[2016/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014140059
Date:18.09.2014
Language:EN
[2014/38]
Type: A1 Application with search report 
No.:EP2970116
Date:20.01.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 18.09.2014 takes the place of the publication of the European patent application.
[2016/03]
Search report(s)International search report - published on:EP18.09.2014
ClassificationIPC:C07C303/40, C07C307/04, C07C307/06, C07C307/08, C07C311/03, C07C311/08, C07C311/22, C07C311/30, C07D241/04, C07D417/10, C07D417/12, C07D285/04, C07D285/06, C07D285/16, C07D285/36
[2016/03]
CPC:
C07D417/12 (EP,US); A61P19/02 (EP); A61P43/00 (EP);
C07D211/96 (EP,US); C07D285/16 (EP,US); C07D285/36 (EP,US);
C07D295/185 (EP,US); C07D401/12 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/03]
TitleGerman:ARYLSULFAMID- UND -SULFAMATDERIVATE ALS RORC-MODULATOREN[2016/03]
English:ARYL SULFAMIDE AND SULFAMATE DERIVATIVES AS RORc MODULATORS[2016/03]
French:DÉRIVÉS D'ARYL SULFAMIDE ET DE SULFAMATE COMME MODULATEURS DE RORC[2016/03]
Entry into regional phase15.10.2015National basic fee paid 
15.10.2015Designation fee(s) paid 
15.10.2015Examination fee paid 
Examination procedure15.10.2015Examination requested  [2016/03]
30.08.2016Amendment by applicant (claims and/or description)
02.02.2018Despatch of a communication from the examining division (Time limit: M04)
13.06.2018Application deemed to be withdrawn, date of legal effect  [2018/46]
10.07.2018Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2018/46]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.02.2018
Request for further processing for:30.08.2016Request for further processing filed
30.08.2016Full payment received (date of receipt of payment)
Request granted
15.09.2016Decision despatched
Fees paidRenewal fee
08.03.2016Renewal fee patent year 03
07.03.2017Renewal fee patent year 04
03.04.2018Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO2008109154  (METASTATIX INC [US], et al) [X] 1-26 * page 2, lines 8-9; page 4, lines 14-17; page 8, line 8 - page 9, line 26; page 11, lines 1-9; claims, e.g. claims 2, 17, 18, 21-24 *;
 [XA]WO2012151451  (AGIOS PHARMACEUTICALS INC [US], et al) [X] 1,4,11-13,16-20,22,26 * page 6, line 15 - page 7, line 14; page 21, line 15 - page 22, line 4; claims, e.g. claim 1 * [A] 2,3,5-10,14,15,21,23-25;
 [Y]US2010280014  (HAUPT ANDREAS [DE], et al) [Y] 1-26 * [0002]; [0005]; [0010, formula I]; [0207, Table A]; [0246]; examples, e.g. Examples 1, 4-7, 9-19, 22-39, 41-44, 50-82, 85-95 and 102-105; claims, e.g. claims 1, 28 and 30 *;
 [Y]WO02053557  (ACTELION PHARMACEUTICALS LTD [CH], et al) [Y] 1-26 * page 1, lines 11-18; page 12, line 1 - page 14, line 4; page 16, lines 3-18; examples, e.g. Examples 46, 52, 141, 216; claims *;
 [Y]WO2004009558  (PTC THERAPEUTICS INC [US], et al) [Y] 1-26 * page 4, formula I; page 26, formula VII; page 28, formula IX; page 32, formula XI; claims, in particular claims 30-32 and 61 *;
 [A]WO2012064744  (LYCERA CORP [US], et al) [A] 1-26 * examples, for example, Table 6, compound VI-I; claims *
by applicant   - Fieser and Fieser's Reagents for Organic Synthesis, WILEY & SONS, (1991), vol. 1-15
    - Rodd's Chemistry of Carbon Compounds, ELSEVIER SCIENCE PUBLISHERS, (1989), vol. 1-5
    - Organic Reactions, WILEY & SONS, (1991), vol. 1-40
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.